Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin
- PMID: 3099540
- DOI: 10.1111/j.1440-1827.1986.tb02822.x
Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin
Abstract
Increased susceptibility to Rhizopus oryzae in diabetes was investigated using mice in which diabetic ketoacidosis was experimentally induced. All of the diabetic mice which had developed ketoacidosis died within four days after inoculation of R. oryzae and their serum UIBCs (Unbound iron binding capacity) were significantly lower than those of the normal control mice. This study suggested that the decreased serum UIBC produced by diabetic ketoacidosis enhances the growth of R. oryzae in vivo.
Similar articles
-
Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.J Clin Invest. 2016 Jun 1;126(6):2280-94. doi: 10.1172/JCI82744. Epub 2016 May 9. J Clin Invest. 2016. PMID: 27159390 Free PMC article.
-
A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.Diabetes. 1982 Dec;31(12):1109-14. doi: 10.2337/diacare.31.12.1109. Diabetes. 1982. PMID: 6816646
-
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.J Clin Invest. 2010 Jun;120(6):1914-24. doi: 10.1172/JCI42164. Epub 2010 May 17. J Clin Invest. 2010. PMID: 20484814 Free PMC article.
-
Pathogenesis of mucormycosis.Clin Infect Dis. 2012 Feb;54 Suppl 1(Suppl 1):S16-22. doi: 10.1093/cid/cir865. Clin Infect Dis. 2012. PMID: 22247441 Free PMC article. Review.
-
A closer look at pathogenesis of cerebral mucormycosis in diabetic condition: A mini review.J Basic Microbiol. 2021 Mar;61(3):212-218. doi: 10.1002/jobm.202000692. Epub 2021 Jan 14. J Basic Microbiol. 2021. PMID: 33448040 Review.
Cited by
-
Experimental Models to Study the Pathogenesis and Treatment of Mucormycosis.J Fungi (Basel). 2024 Jan 22;10(1):85. doi: 10.3390/jof10010085. J Fungi (Basel). 2024. PMID: 38276032 Free PMC article. Review.
-
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.J Antimicrob Chemother. 2012 Mar;67(3):715-22. doi: 10.1093/jac/dkr375. Epub 2011 Sep 20. J Antimicrob Chemother. 2012. PMID: 21937481 Free PMC article. Clinical Trial.
-
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.Mycopathologia. 2021 Dec;186(6):739-754. doi: 10.1007/s11046-021-00584-8. Epub 2021 Aug 19. Mycopathologia. 2021. PMID: 34414555 Free PMC article.
-
Serum iron indices in COVID-19-associated mucormycosis: A case-control study.Mycoses. 2022 Jan;65(1):120-127. doi: 10.1111/myc.13391. Epub 2021 Nov 16. Mycoses. 2022. PMID: 34743358 Free PMC article.
-
Virulence factors of medically important fungi.Clin Microbiol Rev. 1996 Oct;9(4):469-88. doi: 10.1128/CMR.9.4.469. Clin Microbiol Rev. 1996. PMID: 8894347 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical